1 |
Travis EL, Komaki R. Treatment-related lung cancer. In: Pass HI, Carbone DP, Minna JD, Johnson DH, Turrisi AT III. Lung Cancer. Principles and Practice. 3rd ed. Philadelphia, Baltimore, NY, London, Hong Kong, Sydney, Tokyo: Lippincott Williams & Wilkins. 2005:545-567
|
2 |
Beckmann GK, Kolbl O, Krieger T, Wulf J, Flentje MP. How can we further improve radiotherapy for stage-III non-small-cell lung cancer? Lung cancer 2004;45S:125-132
|
3 |
Rengan R, Rosenzweig KE, Venkatraman E, et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;60:741-747
DOI
ScienceOn
|
4 |
Liu HH, Wang CW, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;58:1268-1279
DOI
ScienceOn
|
5 |
Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006;66:1595-1596
PUBMED
|
6 |
Bradley JD, Hope A, Naqa IE, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007;69:985-992
DOI
ScienceOn
|
7 |
Miles EF, Kelsey CR, Kirkpatrick JP, Marks LB. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: Calculations from clinical trials. Int J Radiat Oncol Biol Phys 2007;68:1047-1052
DOI
PUBMED
ScienceOn
|
8 |
Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005;63:5-24
DOI
ScienceOn
|
9 |
Sekine I, Sumi M, Ito Y, et al. Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients. Radiother Oncol 2006;80:93-97
DOI
ScienceOn
|
10 |
Rice DC, Smythe WR, Liao Z, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phy 2007;69:350-357
DOI
ScienceOn
|
11 |
Kimura T, Matsuura K, Murakami Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006;66:483-491
DOI
ScienceOn
|
12 |
Huang EH, Liao Z, Cox JD, et al. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys 2007;68:779-785
DOI
ScienceOn
|
13 |
Dong L, Mohan R. Intensity-modulated radiation therapy, physics and quality assurance. In: Chao KSC, Apisarnthanarax S, Ozigit G. Practical Essentials of Intensity Modulated Radiation Therapy. 2nd ed. Philadelphia, Baltimore, NY, London, Hongkong, Sydney, Tokyo: Lippincott Williams & Wilkins. 2005:2-19
|
14 |
Tsoutsou PG, Koukourakis MI. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 2006;66:1281-1293
DOI
ScienceOn
|
15 |
Onn A, Vaporciyan AA, Chang JY, Komaki R, Roth JA, Herbst RS. Cancer of the lung. In: Kufe DW, Bast RC, Hait WN, et al. Cancer Medicine. 7th ed. Hamilton, London: BC Decker Inc. 2006:1179-1224
|
16 |
Grills IS, Yan DY, Martinez AA, Vicini FA, Wong JW, Kestine LL. Potential for reduced toxicity and dose escalation in the treatment of imoperable non-small cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT) 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 2003;57:875-890
DOI
ScienceOn
|
17 |
Seibert RM, Ramsey CR, Hines JW, et al. A model for predicting lung cancer response to therapy. Int J Radiat Oncol Biol Phys 2007;67:601-609
DOI
ScienceOn
|
18 |
Belderbos JSA, Heemsbergen WD, Jaeger KD, Baas P, Lebesque JV. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:126-134
DOI
ScienceOn
|
19 |
Wall RJ, Schnapp LM. Radiation pneumonitis. Respiratory Care 2006;51:1255-1260
PUBMED
|
20 |
Rojas AM, Lyn BE, Wilson EM, et al. Toxicity and outcome of a phase II trial of Taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer. Cancer 2006;107:1321-1330
DOI
ScienceOn
|
21 |
Choi Y, Lee HS, Hur WJ, et al. Impact of intensity modulated radiation therapy as a boost treatment on the lung dose distributions for non-small-cell lung cancer. Lung Cancer 2005;4:6-14
|
22 |
Boyer AL. Intensity modulated radiation therapy. In: Khan FM. Treatment Planning in Radiation Oncology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2007:142-165
|
23 |
Hope AJ, Linsay PE, Naqa IE, et al. Modeling radiation pneumonitis risk with clinical, dosimetric and spatial parameters. Int J Radiat Oncol Biol Phys 2006;65:112-124
DOI
ScienceOn
|
24 |
Wagner H Jr. Non-small-cell lung cancer. In: Gunderson LL, Tepper JE. Clinical Radiation Oncology. 2nd ed. Churchhill: Livingstone. 2007:911
|
25 |
Weiss E, Ramakrishnan V, Keall PJ. Is there a selection bias in radiotherapy dose-escalation protocols? Int J Radiat Oncol Biol Phys 2007;68:1359-1365
DOI
ScienceOn
|
26 |
Baisden JM, Romney DA, Reish AG, et al. Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors. Int J Radiat Oncol Biol Phys 2007;68:1229-1237
DOI
ScienceOn
|
27 |
Wu KL, Jiang GL, Liao Y, et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. Int J Radiat Oncol Biol Phys 2003;57:2336-1344
|
28 |
Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherpay for advanced-stage non-small-cell lung cancer. Int J Radiat Onol Biol Phys 2004;58:1258-1267
DOI
ScienceOn
|
29 |
Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and tree-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66:1399-1407
DOI
ScienceOn
|
30 |
Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys 2007;67:410-416
DOI
ScienceOn
|
31 |
Giraud P, De Rycke Y, Lavole A, Milleron B, Cosset J-M, Rosenzweig KE. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? Int J Radiat Oncol Biol Phys 2006;64:127-135
DOI
ScienceOn
|